Engel, Christoph 
; Rhiem, Kerstin ; Hahnen, Eric ; Loibl, Sibylle ; Weber, Karsten E. ; Seiler, Sabine ; Zachariae, Silke ; Hauke, Jan ; Wappenschmidt, Barbara ; Waha, Anke ; Blümcke, Britta ; Kiechle, Marion ; Meindl, Alfons ; Niederacher, Dieter ; Bartram, Claus R. ; Speiser, Dorothee ; Schlegelberger, Brigitte ; Arnold, Norbert ; Wieacker, Peter ; Leinert, Elena ; Gehrig, Andrea ; Briest, Susanne ; Kast, Karin ; Riess, Olaf ; Emons, Günter ; Weber, Bernhard H. F. ; Engel, Jutta ; Schmutzler, Rita K.
; Rhiem, Kerstin ; Hahnen, Eric ; Loibl, Sibylle ; Weber, Karsten E. ; Seiler, Sabine ; Zachariae, Silke ; Hauke, Jan ; Wappenschmidt, Barbara ; Waha, Anke ; Blümcke, Britta ; Kiechle, Marion ; Meindl, Alfons ; Niederacher, Dieter ; Bartram, Claus R. ; Speiser, Dorothee ; Schlegelberger, Brigitte ; Arnold, Norbert ; Wieacker, Peter ; Leinert, Elena ; Gehrig, Andrea ; Briest, Susanne ; Kast, Karin ; Riess, Olaf ; Emons, Günter ; Weber, Bernhard H. F. ; Engel, Jutta ; Schmutzler, Rita K. 
Abstract
Background: There is no international consensus up to which age women with a diagnosis of triple-negative breast cancer (TNBC) and no family history of breast or ovarian cancer should be offered genetic testing for germline BRCA1 and BRCA2 (gBRCA) mutations. Here, we explored the association of age at TNBC diagnosis with the prevalence of pathogenic gBRCA mutations in this patient group. Methods: ...
Owner only: item control page
Altmetric